The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy
Keith Dredge, Ian Bytheway, C. P. Li(Alcohol and Drug Foundation), Pauline S. Handley, Vito Ferro(The University of Queensland), Edward Hammond(American Cancer Society), Arvind Gautam(Alcohol and Drug Foundation), Thomas J. Gonda(University of South Australia), Ligong Liu(Australian Research Council), Keith Davis(The Ohio State University), K. Johnstone(Alcohol and Drug Foundation), Norbert Wimmer(The University of Queensland)
Cited by 118
Related Papers
A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
MYB function in normal and cancer cells
|Nature reviews. Cancer|2008|627
Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia
|Nature|1984|569
Transcripts from the Cellular Homologs of Retroviral Oncogenes: Distribution Among Chicken Tissues
|Molecular and Cellular Biology|1982|402